Publications by authors named "Sarah-Jane Dawson"

56Publications

Non-genetic mechanisms of therapeutic resistance in cancer.

Nat Rev Cancer 2020 Dec 8;20(12):743-756. Epub 2020 Oct 8.

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-020-00302-4DOI Listing
December 2020

Combining liquid biopsies and PET-CT for early cancer detection.

Nat Med 2020 07;26(7):1010-1011

Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-020-0970-9DOI Listing
July 2020

Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.

J Mol Diagn 2018 11 28;20(6):883-892. Epub 2018 Aug 28.

Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK Major Centre, Cambridge, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197164PMC
November 2018

Circulating tumor DNA for disease monitoring in the era of CAR T-cell therapy.

Leuk Lymphoma 2019 02 20;60(2):279-280. Epub 2018 Aug 20.

a Peter MacCallum Cancer Centre , Melbourne , Victoria , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1485916DOI Listing
February 2019

Characterizing the Cancer Genome in Blood.

Cold Spring Harb Perspect Med 2019 04 1;9(4). Epub 2019 Apr 1.

Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne 3000, Australia; Centre for Cancer Research, University of Melbourne, Melbourne 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/cshperspect.a026880DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444693PMC
April 2019

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.

N Engl J Med 2018 03;378(13):1211-1223

From the Peter MacCallum Cancer Centre, Melbourne, VIC (C.S.T., M.A.A., R.A., S.H., R.J.H., K.B., G.T., J.D.I., M.B., D.W., S.L., S.-J.D., M.A.D., J.F.S., A.W.R.), and the Victorian Comprehensive Cancer Centre (C.S.T., M.A.A., R.A., S.H., R.J.H., K.B., D.W., S.-J.D., M.A.D., J.F.S., A.W.R.), the Faculty of Medicine (C.S.T., R.J.H., S.-J.D., M.A.D., J.F.S., A.W.R.) and Centre for Cancer Research (S.-J.D., M.A.D.), University of Melbourne, the Department of Clinical Haematology and Bone Marrow Transplantation, the Royal Melbourne Hospital (C.S.T., M.A.A., K.B., J.F.S., A.W.R.), and the Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research (M.A.A., A.W.R.), Parkville, VIC - all in Australia; and the University Hospital of Schleswig-Holstein, Kiel (C.P.), and Klinikum der Universität, Ludwig-Maximilian University of Munich, Munich (M.D.) - both in Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1715519DOI Listing
March 2018

The value of cell-free DNA for molecular pathology.

J Pathol 2018 04 12;244(5):616-627. Epub 2018 Mar 12.

Marie-José and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656375PMC
April 2018

Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2018 02 3;36(6):523-524. Epub 2018 Jan 3.

Andjelija Zivanovic Bujak and Sarah-Jane Dawson, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5461DOI Listing
February 2018

Wet or Dry? Do Liquid Biopsy Techniques Compete with or Complement PET for Disease Monitoring in Oncology?

J Nucl Med 2017 06 27;58(6):869-870. Epub 2017 Apr 27.

Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.190116DOI Listing
June 2017

Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer.

J Clin Oncol 2017 Apr 13;35(12):1274-1280. Epub 2017 Feb 13.

Elizabeth L. Christie, Sian Fereday, Ken Doig, Sarah-Jane Dawson, and David D.L. Bowtell, Peter MacCallum Cancer Centre, Melbourne; Elizabeth L. Christe, Ken Doig, Sarah-Jane Dawson, David D.L. Bowtell, University of Melbourne, Melbourne, Victoria; and Swetansu Pattnaik and David D.L. Bowtell, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.4627DOI Listing
April 2017

Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.

Cancer Res 2016 10;76(19):5590-5591

Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. The Kinghorn Cancer Centre, Garvan Institute for Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-2281DOI Listing
October 2016

Large B-cell lymphoma: is the future written in the blood?

Lancet Oncol 2015 May 1;16(5):481-3. Epub 2015 Apr 1.

Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70160-9DOI Listing
May 2015

Analysis of circulating tumor DNA to monitor metastatic breast cancer.

N Engl J Med 2013 Mar 13;368(13):1199-209. Epub 2013 Mar 13.

Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1213261DOI Listing
March 2013

A new genome-driven integrated classification of breast cancer and its implications.

EMBO J 2013 Mar 8;32(5):617-28. Epub 2013 Feb 8.

Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emboj.2013.19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590990PMC
March 2013

Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.

J Pathol 2012 Jul 8;227(3):306-14. Epub 2012 May 8.

Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.3983DOI Listing
July 2012

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

Breast Cancer Res 2011 23;13(6):R118. Epub 2011 Nov 23.

Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326560PMC
June 2012

A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.

J Pathol 2012 Jan 26;226(1):97-107. Epub 2011 Sep 26.

Department of Oncology, University of Cambridge, Cambridge, CB1 9RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2976DOI Listing
January 2012

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Cancer Res 2011 Oct 15;71(19):6240-9. Epub 2011 Aug 15.

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-1266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327299PMC
October 2011

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

Clin Cancer Res 2008 May 29;14(10):2953-61. Epub 2008 Apr 29.

Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Department, Peter MacCallum Cancer Centre, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-5237DOI Listing
May 2008

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.

Anticancer Drugs 2008 Jun;19(5):547-52

Department of Haematology and Medical Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3282fc6cf7DOI Listing
June 2008

Hypocalcemia associated with bone metastases in a patient with salivary-gland carcinoma.

Nat Clin Pract Oncol 2006 Feb;3(2):104-7

Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0405DOI Listing
February 2006

Images in clinical medicine. Cerebral metastases in breast cancer.

N Engl J Med 2005 Oct;353(16):1724

St. Vincent's Hospital, Victoria 3065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMicm050569DOI Listing
October 2005